Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine

Clinical Infectious Diseases

Volumn 28, Issue 5, 1999, Pages 1100-1103

  Tantawichien, Terapong ^a,b   Benjavongkulchai, Maneerat ^a   Limsuwan, Kornvika ^a   Khawplod, Pakamatz ^a   Kaewchompoo, Wilaiwan ^a   Chomchey, Prance ^a   Sitprija, Visith ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; RABIES VACCINE;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RABIES; VACCINATION; VERO CELL;

EID: 0032909091     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514737     Document Type: Article

References (29)

1. 1. WHO Expert Committee on Rabies. Eighth report. World Health Organ Tech Rep Ser 1992; series 824.
2. 2. World Health Organization. WHO consultation on intradermal application of human rabies vaccines (Geneva). WHO/Rab. Res./95.47. Geneva: World Health Organization, 13-14 March 1995.
3. 3. Smith JS, Yager PA, Baer GM. A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ 1973;48:535-41.
4. 4. Suss J, Sinnecker H. Immune reactions against rabies virus infection and vaccination. Exp Pathol 1991;42:1-9.
5. 5. Plotkin SA, Koprowski H. Rabies vaccine. In Plotkin SA, Mortimer EA, eds. Vaccines. 2nd ed. Philadelphia: WB Saunders, 1994;649-70.
6. 6. Rosanoff E, Tint H. Responses to human diploid cell rabies vaccine: neutralizing antibody responses of vaccinees receiving booster doses of human diploid cell rabies vaccine. Am J Epidemiol 1979;110:322-7.
7. 7. Fishbein DB, Bernard KW, Miller KD, et al. The early kinetics of the neutralizing antibody response after booster immunizations with human diploid cell rabies vaccine. Am J Trop Med Hyg 1986;35:663-70.
8. 8. Fayaz A, Simani S, Nour-Salchi S, Bahmanyar M. Booster effect of human diploid cell antirabies vaccine in previously treated persons. JAMA 1981;246:2334-5.
9. 9. Burridge MJ, Baer GM, Sumner JW, Sussman O. Intradermal immunization with human diploid cell rabies vaccine. JAMA 1982;248:1611-4.
10. 10. Bernard KW, Roberts MA, Sumner J, et al. Human diploid cell rabies vaccine: effectiveness of immunization with small intradermal or subcutaneous doses. JAMA 1982;247:1138-42.
11. 11. Burridge MJ, Sumner JW, Baer GM. Intradermal immunization with human diploid cell rabies vaccine: serological und clinical responses of immunized persons to intradermal booster vaccination. Am J Public Health 1984;74:503-5.
12. 12. Rodrigues FM, Mandke VB, Roumiantzeff M, et al. Persistence of rabies antibody 5 years after pre-exposure prophylaxis with human diploid cell antirabies vaccine and antibody response to a single booster dose, Epidemiol Infect 1987;99:91-5.
13. 13. Suntharasamai P, Chanthavanich P, Supanaranond V, Warrell MJ. One year booster vaccination with purified Vero cell rabies vaccine. Trans R Soc Trop Med Hyg 1988;82:633.
14. 14. Vodopija R, Lafont M, Baklaic Z, Ljubicic M, Syjetlicic M, Vodopija I, Persistence of humoral immunity to rabies 1100 days after immunization and effect of a single booster dose of rabies vaccine. Vaccine 1997;15:571-4.
15. 15. Dressen DW, Fishbein DB, Kemp DT, Brown J. Two-year comparative trial on the immunogenicity and adverse effects of purified chick embryo cell rabies vaccine for pre-exposure immunization. Vaccine 1989;7:397-400.
16. 16. Plotkin SA. Rabies vaccine prepared in human cell culture: progress and perspective. Rev Infect Dis 1980;2:433-48.
17. 17. Crowle AJ, Atkins A, May M. Induction of delayed hypersensitivity to protein antigens in mice without Freund's adjuvants. J Allergy Clin Immunol 1977;60:14-26.
18. 18. Nicholson KG, Prestage H. Multisite intradermal antirabies vaccination. Lancet 1981;2:915-7.
19. 19. Warrell MJ, Warrell DA, Suntharasamai P, et al. An economical regimen of human diploid cell strain anti-rabies vaccine for post-exposure prophylaxis. Lancet 1983;2:301-4.
20. 20. Warrell MJ, Suntharasamai P, Nicholson KG, et al. Multi-site intradermal and multi-site subcutaneous rabies vaccination: improved economical regimens. Lancet 1984;1:874-6.
21. 21. Warrell MJ, Nicholson KG, Warrell DA, et al. Economical multiple-site intradermal immunization with human diploid-cell-strain vaccine is effective for post-exposure rabies prophylaxis. Lancet 1985;1:1059-62.
22. 22. Suntharasamai P, Warrell MJ, Warrell DA, et al. Early antibody responses to rabies post-exposure vaccine regimens. Am J Trop Med Hyg 1987; 36:160-5.
23. 23. Phanuphak P, Khawplod P, Sirivichayakul S, Siriprasomsub W, Sukathida U, Thaweepathomwat M. Humoral and cell-mediated immune responses to various economical regimens of purified Vero cell rabies vaccine. Asian Pac J Allergy Immunol 1987;5:33-7.
24. 24. Berlin BS, Goswick C. Rapidity of booster response to rabies vaccine produced in cell culture. J Infect Dis 1984;150:785.
25. 25. Turner GS. Immunoglobulin (IgG) and (IgM) antibody responses to rabies vaccine. J Gen Virol 1978;40:595-604.
26. 26. Nicholson KG, Turner GS, Aoki FY. Immunization with a human diploid cell strain of rabies virus vaccine: two-year results. J Infect Dis 1978; 137:783-8.
27. 27. Turner GS, Nicholson KG, Tyrrell DA, Aoki FY. Evaluation of a human dipioid cell strain rabies vaccine: final report of a three year study of pre-exposure immunization. J Hyg (Lond) 1982;89:101-10.
28. 28. Kositprapa C, Limsuwan K, Wilde H, et al. Immune response to stimulated postexposure rabies booster vaccinations in volunteers who received preexposure vaccinations. Clin Infect Dis 1997;25:614-6.
29. 29. Bernard KW, Fishbein DB, Miller KD, et al. Pre-exposure rabies immunization with human diploid cell vaccine: decreased antibody responses in persons immunized in developing countries. Am J Trop Med Hyg 1985;34:633-47.